sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients

BACKGROUND: Measurement of prostate-specific antigen (PSA) advanced the diagnostic and prognostic potential for prostate cancer (PCa). However, due to PSA’s lack of specificity, novel biomarkers are needed to improve risk assessment and ensure optimal personalized therapy. A set of protein molecules...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsaur, Igor, Thurn, Kristina, Juengel, Eva, Gust, Kilian M., Borgmann, Hendrik, Mager, Rene, Bartsch, Georg, Oppermann, Elsie, Ackermann, Hanns, Nelson, Karen, Haferkamp, Axel, Blaheta, Roman A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490684/
https://www.ncbi.nlm.nih.gov/pubmed/25967040
http://dx.doi.org/10.1186/s13046-015-0161-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490684/
https://www.ncbi.nlm.nih.gov/pubmed/25967040
http://dx.doi.org/10.1186/s13046-015-0161-6

Ejemplares similares